Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term

Journal of Gastrointestinal Surgery

Volumn 9, Issue 7, 2005, Pages 955-960

  Suzuki, Yutaka ^a   Ishibashi, Yoshio ^a   Omura, Nobuo ^a   Kawasaki, Naruo ^a   Kashiwagi, Hideyuki ^a   Yanaga, Katsuhiko ^a   Abo, Masahiro ^a   Urashima, Mitsuyoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bisphosphonate; Bone mineral density; Gastrectomy; Osteomalacia; Osteopenia

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; AMINO ACID; BONE DENSITY CONSERVATION AGENT; CALCIUM; COLECALCIFEROL; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD; BONE DENSITY; DRUG EFFECT; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LONGITUDINAL STUDY; LOW BACK PAIN; MALE; METABOLIC BONE DISEASE; MIDDLE AGED; PROSPECTIVE STUDY; RADIUS FRACTURE; STOMACH BYPASS; STOMACH TUMOR; URINE;

ADULT; AGED; ALENDRONATE; ALKALINE PHOSPHATASE; AMINO ACIDS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCIUM; CHOLECALCIFEROL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC BYPASS; HUMANS; LONGITUDINAL STUDIES; LOW BACK PAIN; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RADIUS FRACTURES; STOMACH NEOPLASMS;

EID: 24044538885     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.04.020     Document Type: Article

References (35)

1. C.W. Deveney, D. MacCabee, K. Marlink, K. Welker, J. Davis, and D.B. McConnell Roux-en-Y divided gastric bypass results in the same weight loss as duodenal switch for morbid obesity Am J Surg 187 2004 655 659
2. G. Almogy, P.F. Crookes, and G.J. Anthone Longitudinal gastrectomy as a treatment for the high-risk super-obese patient Obes Surg 14 2004 492 497
3. P. Hohenberger, and S. Gretschel Gastric cancer Lancet 362 2003 305 315
4. K.M. Flegal, M.D. Carroll, C.L. Ogden, and C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
5. C.N. Bernstein, W.D. Leslie, and M.S. Leboff AGA technical review on osteoporosis in gastrointestinal diseases Gastroenterology 124 2003 795 841
6. P. Filipponi, F. Gregorio, and S. Cristallini Partial gastrectomy and mineral metabolism: Effects on gastrin-calcitonin release Bone Miner 11 1990 199 208
7. L. Nilas, and C. Christiansen Influence of PTH and 1, 25(OH)2D on calcium homeostasis and bone mineral content after gastric surgery Calcif Tiss Int 37 1985 461 466
8. H. Resch, P. Pietschmann, B. Pernecker, E. Krexner, and R. Willvonseder The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density Clin Invest 70 1992 426 429
9. A.M. Parfitt, M.K. Drezner, and F.H. Glorieux Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 1987 595 610
10. P.S. Coates, J.D. Fernstrom, M.H. Fernstrom, P.R. Schauer, and S.L. Greenspan Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass J Clin Endocrinol Metab 89 2004 1061 1065
11. D.B. Morgan, C.R. Paterson, C.G. Woods, C.N. Pulvertaft, and P. Fouman Search for osteomalacia in 1228 patients after gastrectomy and other operations on the stomach Lancet 2 1965 1085 1088
12. F.I. Tovey, M.L. Hall, P.J. Ell, and M. Hobsley A review of postgastrectomy bone disease J Gastroenterol Hepatol 7 1992 639 645
13. F.I. Tovey, M.L. Hal, P.J. Ell, and M. Hobsley Postgastrectomy osteoporosis Br J Surg 78 1991 1335 1337
14. M. Davies, S.E. Heys, P.L. Selby, J.L. Berry, and E.B. Mawer Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease J Clin Endocrinol Metab 82 1997 209 212
15. C. Ichikawa, N. Takiguchi, K. Koda, K. Oda, H. Suzuki, and M. Miyazaki Early phase metabolic bone disorders after gastrectomy: Influence of active vitamin D treatment Dig Dis Sci 47 2002 1886 1890
16. Y. Rino, T. Imada, Y. Yamamoto, M. Takahashi, T. Amano, and Y. Takanashi The efficacy of 1 alpha hydroxy vitamin D3 treatment of the metabolic bone disorder in patients who underwent gastrectomy for gastric cancer Hepatogastroenterology 47 2000 1498 1500
17. D. Lehto-Axtelius, V.V. Surve, O. Johnell, and R. Hakanson Effects of calcium deficiency and calcium supplementation on gastrectomy-induced osteopaenia in the young male rat Scand J Gastroenterol 37 2002 299 306
18. V.V. Surve, P. Hoglund, and R. Hakanson Gastrectomized rats respond with exaggerated hypercalcemia to oral and intravenous calcium loads because of impaired ability of bone to take up Ca2+ Scand J Gastroenterol 37 2002 523 530
19. Y. Suzuki, S. Fukushima, and T. Iwai Bisphosphonate incadronate prevents total gastrectomy-induced osteopenia in rats Bone 35 2004 1346 1352
20. J.A. Cuzick Wilcoxon-type test for trend Stat Med 4 1985 87 90
21. H.G. Bone, D. Hosking, and J.P. Devogelaer Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 350 2004 1189 1199
22. S. Evio, A. Tiitinen, K. Laitinen, O. Ylikorkala, and M.J. Valimaki Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis J Clin Endocrinol Metab 89 2004 626 631
23. W.M. Drake, D.L. Kendler, C.J. Rosen, and E.S. Orwoll An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men J Clin Endocrinol Metab 88 2003 5759 5765
24. J.D. Ringe, H. Faber, and A. Dorst Alendronate treatment of established primary osteoporosis in men: Results of a 2-year prospective study J Clin Endocrinol Metab 86 2001 5252 5255
25. L.S. Rosen, D. Gordon, and M. Kaminski Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial Cancer 98 2003 1735 1744
26. J.J. Body, I.J. Diel, and M. Lichinitzer Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies Br J Cancer 90 2004 1133 1137
27. S.D. Reed, J.I. Radeva, G.A. Glendenning, F. Saad, and K.A. Schulman Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer J Urol 171 2004 1537 1542
28. M.R. Smith, J.S. Finkelstein, and F.J. McGovern Changes in body composition during androgen deprivation therapy for prostate cancer J Clin Endocrinol Metab 87 2002 599 603
29. N. Andersson, V.V. Surve, and D. Lehto-Axtelius Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat J Endocrinol 175 2002 695 703
30. B. Klings, D. Lhto-Axelius, M. Akerman, and R. Hakanson Structure of calvaria after gastrectomy. An experimental study in the rat Scand J Gastroenterol 30 1995 952 957
31. M.R. Clements, L. Johnson, and D.R. Fraser A new mechanism for induced vitamin D deficiency in calcium deprivation Nature 325 1987 62 65
32. H.V. Lilienfeld-Toal, K.G. Mackes, G. Kodrat, H. Ochs, and A. Sonnenberg Plasma 25-hydroxyvitamin D and urinary cyclic AMP in German patients after gastrectomy Am J Dig Dis 22 1977 633 666
33. D.B. Morgan, G. Hunt, and C.R. Paterson Osteomalacia syndrome after stomach operations Q J Med 39 1970 395 410
34. C.C. Chow, W.B. Chan, and J.K. Li Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism J Clin Endocrinol Metab 88 2003 581 587
35. C.R. Parker, P.J. Blackwell, K.J. Fairbairn, and D.J. Hosking Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: A 2-year study J Clin Endocrinol Metab 87 2002 4482 4489